Therapeutic Inhibition of the Receptor Tyrosine Kinase AXL Improves Sensitivity to Platinum and Taxane in Ovarian Cancer

Ovarian cancer (OvCa), one of the deadliest malignancies in female cancer patients, is characterized by recurrence and poor response to cytotoxic chemotherapies. Fewer than 30% of patients with resistant disease will respond to additional chemotherapy treatments. This study aims to determine whether...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Cancer Ther
Main Authors: Quinn, Jeanne M., Greenwade, Molly M., Palisoul, Marguerite L., Opara, Gregory, Massad, Katina, Guo, Lei, Zhao, Peinan, Beck-Noia, Hollie, Hagemann, Ian S., Hagemann, Andrea R., McCourt, Carolyn K., Thaker, Premal H., Powell, Matthew A., Mutch, David G., Fuh, Katherine C.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6363844/
https://ncbi.nlm.nih.gov/pubmed/30478151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-18-0537
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares